Cargando…
DNA Methylation at ATP11A cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal Study
Cystic fibrosis (CF) is a chronic genetic disease that mainly affects the respiratory and gastrointestinal systems. No curative treatments are available, but the follow-up in specialized centers has greatly improved the patient life expectancy. Robust biomarkers are required to monitor the disease,...
Autores principales: | Pineau, Fanny, Caimmi, Davide, Taviaux, Sylvie, Reveil, Maurane, Brosseau, Laura, Rivals, Isabelle, Drevait, Margot, Vachier, Isabelle, Claustres, Mireille, Chiron, Raphaël, De Sario, Albertina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003783/ https://www.ncbi.nlm.nih.gov/pubmed/33808877 http://dx.doi.org/10.3390/genes12030441 |
Ejemplares similares
-
DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis
por: Magalhães, Milena, et al.
Publicado: (2017) -
Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis
por: Pineau, Fanny, et al.
Publicado: (2020) -
Heterochromatic Genes Undergo Epigenetic Changes and Escape Silencing in Immunodeficiency, Centromeric Instability, Facial Anomalies (ICF) Syndrome
por: Brun, Marie-Elisabeth, et al.
Publicado: (2011) -
Rhinovirus‐associated pulmonary exacerbations show a lack of FEV
(1) improvement in children with cystic fibrosis
por: Cousin, Mathias, et al.
Publicado: (2016) -
BAGE Hypomethylation Is an Early Event in Colon Transformation and Is Frequent in Histologically Advanced Adenomas
por: Lana, Erica, et al.
Publicado: (2009)